Anuloma Viloma TimerWorld Hypertension Day is today, May 17, 2026. The World Health Organization is running its “Controlling Hypertension Together” campaign across hundreds of countries. The standard public-health message is the usual mix: diet, movement, sleep, medication. There is a quieter line, recently sharpened by a peer-reviewed paper, that does not appear in any of those campaigns.
A 2025 review in the Journal of Traditional and Complementary Medicine, “Breathing and the Brain: Pranayama, an Ancient Self-Directed Approach to Neuromodulation,” makes a structural claim about pranayama that is worth taking seriously. The paper places pranayama, the family of breath-control techniques codified in classical yoga texts, in the same intervention category as transcranial magnetic stimulation, vagus nerve stimulation devices, and transcranial direct-current stimulation.
That is not a wellness magazine line. That is a category placement in the peer-reviewed literature. The paper argues that pranayama produces effects on the same neural circuits these devices target, without requiring any hardware. The specific technique it names as a mechanism is unilateral nostril breathing. In Sanskrit, that practice is called Anuloma Viloma, alternate nostril breathing.
What “neuromodulation” actually means
Neuromodulation, in clinical use, refers to interventions that alter nervous system activity using targeted physical or electrical signals. Transcranial magnetic stimulation passes a magnetic pulse through the skull to influence cortical neurons. Vagus nerve stimulation uses an implanted or wearable device to send electrical signals along the vagus nerve, the longest cranial nerve and the main parasympathetic highway between brain and viscera. Transcranial direct-current stimulation runs a low-level electrical current through scalp electrodes to shift cortical excitability. These are well-studied tools used in clinical settings for depression, epilepsy, treatment-resistant anxiety, and chronic pain.
The 2025 paper argues that pranayama belongs in the same class of intervention. The reasoning is mechanistic: slow, structured nasal breathing activates baroreceptors and chemoreceptors in the carotid sinuses, modulates the firing rate of the vagus nerve, shifts autonomic balance toward the parasympathetic state, and produces measurable changes in heart rate variability, cortical oscillation patterns, and blood pressure. These are the same end points the hardware-based interventions target. The paper notes that pranayama achieves them through respiratory mechanics alone, with no external energy source and no implanted hardware.
This is not the soft “breathing is good for you” claim that wellness content has been making for decades. It is a specific argument about mechanism and category.
The technique the paper names
The mechanism described in the paper, unilateral nostril breathing, is the structural feature of Anuloma Viloma. The technique alternates the inhale and exhale between the two nostrils, typically with a brief breath hold (kumbhaka) between phases. A standard session runs four to ten minutes. There is no equipment beyond a finger or thumb to close one nostril at a time.
A separate 2026 open-access systematic review on ScienceDirect pooled seven randomised controlled trials with 683 hypertensive participants. The pooled estimates were a significant reduction in heart rate (SMD -0.43, I² = 0) and a significant reduction in systolic blood pressure (SMD -0.72). The participants included people already on antihypertensive medication, which matters because adding a non-pharmacological intervention to existing therapy without disrupting it is the realistic case for most adults living with high blood pressure. The 2025 PMC11996816 Nadi Shodhan RCT (SAGE Annals of Neurosciences) found the same direction of effect on blood pressure with the technique named explicitly by its Sanskrit name, Anulom-Vilom, in patients already on medication.
The earlier 2026 Frontiers for Young Minds paper on slow breathing, written for a general audience, describes the same mechanism in simpler language: slow nasal breathwork activates vagal pathways and shifts the autonomic nervous system toward the parasympathetic state. The peer review on the underlying physiology is consistent across multiple journals and audiences. The 2025 neuromodulation framing is the most assertive category claim of the lot.
Why this matters today
LifeX Research designated vagus nerve exercises as the number one wellness trend of 2026. Wearable vagus nerve stimulators are getting category review attention and are being sold at price points typical of mid-range consumer electronics. None of those reviews mention that the same neural pathway is accessible for free, on any phone, in any quiet room, using a technique that predates printed medicine by a couple of millennia.
The clean question, after the 2025 paper, is not “does pranayama work” but “given that a peer-reviewed paper just placed this practice in the same intervention category as TMS and VNS, why is the practice not a first-line recommendation in standard hypertension protocols.” That is a question for the field, not for an app blog. The smaller question for an individual reader is what to do this Sunday afternoon, on World Hypertension Day, while the WHO campaign runs and the search query “breathing exercises blood pressure” is at its weekly peak.
The answer is straightforward. Find five to ten minutes. Sit upright. Close the right nostril with the thumb, inhale slowly through the left. Close the left, hold briefly, exhale through the right. Inhale through the right. Close the right, hold briefly, exhale through the left. That is one round. Do five to ten of them. Notice that the technique is doing exactly what the paper describes, without any hardware, without any subscription, without any prescription.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.